The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques
Open Access
- 1 March 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 16 (3), e1008339
- https://doi.org/10.1371/journal.ppat.1008339
Abstract
Despite the success of antiretroviral therapy (ART) to halt viral replication and slow disease progression, this treatment is not curative and there remains an urgent need to develop approaches to clear the latent HIV reservoir. The human IL-15 superagonist N-803 (formerly ALT-803) is a promising anti-cancer biologic with potent immunostimulatory properties that has been extended into the field of HIV as a potential "shock and kill" therapeutic for HIV cure. However, the ability of N-803 to reactivate latent virus and modulate anti-viral immunity in vivo under the cover of ART remains undefined. Here, we show that in ART-suppressed, simian-human immunodeficiency virus (SHIV)(SF162P3)-infected rhesus macaques, subcutaneous administration of N-803 activates and mobilizes both NK cells and SHIV-specific CD8+ T cells from the peripheral blood to lymph node B cell follicles, a sanctuary site for latent virus that normally excludes such effector cells. We observed minimal activation of memory CD4+ T cells and no increase in viral RNA content in lymph node resident CD4+ T cells post N-803 administration. Accordingly, we found no difference in the number or magnitude of plasma viremia timepoints between treated and untreated animals during the N-803 administration period, and no difference in the size of the viral DNA cell-associated reservoir post N-803 treatment. These results substantiate N-803 as a potent immunotherapeutic candidate capable of activating and directing effector CD8+ T and NK cells to the B cell follicle during full ART suppression, and suggest N-803 must be paired with a bona fide latency reversing agent in vivo to facilitate immune-mediated modulation of the latent viral reservoir. Author summary IL-15 regulates NK and memory T cell homeostasis and is therefore being explored for clinical immunotherapy of chronic diseases like cancer and HIV. To explore the applicability of the clinical grade IL-15 superagonist N-803 to HIV cure strategies we tested the impact of N-803 on host immunity and latent virus in SHIV-infected rhesus macaques. Our results suggest that N-803 beneficially modulates effector NK and CD8+ T cells by expanding the numbers of these cells and redistributing them to lymph node B cell follicles, a site known to harbor persistent latent virus during ART. However, our results further suggest that N-803 does not perturb the viral reservoir present in memory CD4+ T cells and that in order to fully unlock the immunotherapeutic potential of N-803 it must be paired with latency reversal agents.Funding Information
- National Institute of Allergy and Infectious Diseases (AI128970)
- National Institute of Allergy and Infectious Diseases (AI129703)
- National Institute of Allergy and Infectious Diseases (AI140888)
- NIH Office of the Director (OD011092)
- NIH Office of the Director (OD026561)
This publication has 39 references indexed in Scilit:
- Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin PatientPLoS Pathogens, 2013
- IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterizationCytokine, 2011
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaquesBlood, 2011
- Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primatesBlood, 2010
- Novel Human Interleukin-15 AgonistsThe Journal of Immunology, 2009
- Long-Term Control of HIV byCCR5Delta32/Delta32 Stem-Cell TransplantationThe New England Journal of Medicine, 2009
- IL-15 induces CD4+ effector memory T cell production and tissue emigration in nonhuman primatesJCI Insight, 2006
- Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDSJournal of Medical Primatology, 2005
- Interleukin-15 Increases Effector Memory CD8+T Cells and NK Cells in Simian Immunodeficiency Virus-Infected MacaquesJournal of Virology, 2005